BIO–IVT Group provides biological products to the early stage drug discovery and development industry. The companies’ products include a complete range of plasma, serum, tissue and cellular material products. BIO–IVT provides researchers with the biological tools they need to pursue new drug discovery and development and to validate the safety and efficacy of new compounds during pre-clinical research and in clinical diagnostics.
BIO–IVT Group was acquired by Thompson Street Capital Partners on July 01, 2013.
Join Mergr to view all 338 acquisitions of healthcare services companies in 2013, including 57 acquisitions by private equity firms, and 281 by strategics.
Out of 60 sectors in the Mergr database, healthcare services ranked 4 in number of deals in 2013. The largest healthcare services acquisition in 2013 was Elan - which was acquired by Perrigo Company for $8.6B.
Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like BIO–IVT Group.
No obligation. Cancel anytime.